Open access
Open access
Powered by Google Translator Translator

Ophthalmology

Joint Statement: Hydroxychloroquine use with respect to retinal toxicity

28 Feb, 2021 | 20:41h | UTC

ACR, AAD, RDS, and AAO 2020 Joint Statement on Hydroxychloroquine Use with Respect to Retinal Toxicity – Arthritis & Rheumatism

Commentary: Societies Agree on Eye Safety for HCQ – MedPage Today (free registration required) AND ACR, medical societies reach consensus on hydroxychloroquine retinopathy – Healio (free registration required)

 

Commentary on Twitter

 


Experts worry screen time during Covid-19 could increase vision problems in kids

23 Feb, 2021 | 01:48h | UTC

‘A doozy of a year’: Experts worry screen time during Covid-19 could increase vision problems in kids – STAT

Related: Progression of myopia in school-aged children after COVID-19 home confinement – JAMA Ophthalmology

 


The Lancet Commission on Global Eye Health: Vision Beyond 2020

19 Feb, 2021 | 02:38h | UTC

Global Eye Health: vision beyond 2020 – The Lancet Global Health

 

Commentary on Twitter

 


Ocular MRI findings in patients with severe COVID-19

17 Feb, 2021 | 01:42h | UTC

Ocular MRI Findings in Patients with Severe COVID-19: A Retrospective Multicenter Observational Study – Radiology

Commentaries: New COVID-19 side effect: MRI links severe infection to dangerous eye problems – Health Imaging AND MRI illuminates COVID-19’s negative impact on the eyes – AuntMinnie AND Windows of Infection: MRI Reveals COVID-19-Linked Eye Abnormalities – Diagnostic Imaging

 


Pediatric eye injuries by hydroalcoholic gel in the context of the Covid-19 Pandemic

12 Feb, 2021 | 02:12h | UTC

Pediatric Eye Injuries by Hydroalcoholic Gel in the Context of the Coronavirus Disease 2019 Pandemic – JAMA Ophthalmology

Case series: Hand Sanitizer–Induced Ocular Injury: A COVID-19 Hazard in Children – JAMA Ophthalmology

Invited commentary: Unintended Consequences of Hand Sanitizer Use in the Coronavirus Disease 2019 Pandemic – JAMA Ophthalmology

 


State of the Art Review: Uveitis for the non-ophthalmologist

4 Feb, 2021 | 01:22h | UTC

Uveitis for the non-ophthalmologist – The BMJ (free for a limited period)

 


Systematic review: Worldwide incidence and prevalence of Neuromyelitis Optica

29 Jan, 2021 | 01:31h | UTC

Worldwide Incidence and Prevalence of Neuromyelitis Optica: A Systematic Review – Neurology

 


Referral for disease-related visual impairment using retinal photograph-based deep learning: a proof-of-concept, model development study

22 Jan, 2021 | 08:16h | UTC

Referral for disease-related visual impairment using retinal photograph-based deep learning: a proof-of-concept, model development study – The Lancet Digital Health

Invited commentary: AI-automated referral for patients with visual impairment – The Lancet Digital Health

 

Commentary on Twitter

 


Predicting the risk of developing diabetic retinopathy using deep learning

22 Jan, 2021 | 08:15h | UTC

Predicting the risk of developing diabetic retinopathy using deep learning – The Lancet Digital Health

 

Commentary on Twitter

 


Progression of myopia in school-aged children after COVID-19 home confinement

15 Jan, 2021 | 08:55h | UTC

Progression of Myopia in School-Aged Children After COVID-19 Home Confinement – JAMA Ophthalmology

Commentaries: 2020 as the Year of Quarantine Myopia – JAMA Ophthalmology AND How Does Home Confinement Impact Children’s Eyesight? – AJMC AND COVID-19: Home Quarantine Linked to Increase in Myopia Among Younger Children – NEJM Journal Watch AND Vision problems arise in young school kids in COVID-19 quarantine – CIDRAP

Interview: 2020 as the Year of Quarantine Myopia

 


Randomized trial: Surgical and drug treatment options lead to similar outcomes for diabetic eye disease

15 Jan, 2021 | 08:22h | UTC

Surgical and drug treatment options lead to similar outcomes for diabetic eye disease – NIH News Release

Original Study: Effect of Intravitreous Aflibercept vs Vitrectomy With Panretinal Photocoagulation on Visual Acuity in Patients With Vitreous Hemorrhage From Proliferative Diabetic Retinopathy: A Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)

 

Commentary on Twitter

 


Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study

16 Dec, 2020 | 09:57h | UTC

Trends in prevalence of blindness and distance and near vision impairment over 30 years: an analysis for the Global Burden of Disease Study – The Lancet Global Health

Related article: Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: the Right to Sight: an analysis for the Global Burden of Disease Study – The Lancet Global Health

Commentary: Researchers Say We’re Watching The World Go Blind – Michigan Medicine – University of Michigan

 

Commentaries on Twitter

 

(thread – click for more)

 


Randomized trial: Short-term topical tetracaine is highly efficacious for the treatment of pain caused by corneal abrasions

2 Nov, 2020 | 02:17h | UTC

Short-Term Topical Tetracaine Is Highly Efficacious for the Treatment of Pain Caused by Corneal Abrasions: A Double-Blind, Randomized Clinical Trial – Annals of Emergency Medicine

 


[Abstract Only] Randomized trial: Effect of High add power, medium add power, or single-vision contact lenses on myopia progression in children

2 Sep, 2020 | 09:33h | UTC

Effect of High Add Power, Medium Add Power, or Single-Vision Contact Lenses on Myopia Progression in Children: The BLINK Randomized Clinical Trial – JAMA

Commentaries: Multifocal contact lenses slow myopia progression in children – NIH News Releases AND Young nearsighted kids benefit from bifocal contact lenses, study shows – Ohio State University

 


A Deep Learning Algorithm to Detect Chronic Kidney Disease from Retinal Photographs

29 May, 2020 | 03:02h | UTC

A deep learning algorithm to detect chronic kidney disease from retinal photographs in community-based populations – The Lancet Digital Health

Commentary: Opportunistic deep learning of retinal photographs: the window to the body revisited – The Lancet Digital Health

 

Related Commentary on Twitter

 


COVID-19 Disease and Ophthalmology: An Update

26 May, 2020 | 09:30h | UTC

COVID-19 Disease and Ophthalmology: An Update – Ophthalmology and Therapy

Related: Characteristics of Ocular Findings of Patients With Coronavirus Disease

 


ASCO Guideline: Management of Cancer Cachexia

21 May, 2020 | 09:13h | UTC

Management of Cancer Cachexia: ASCO Guideline – Journal of Clinical Oncology

 


Predicting Conversion to Wet Age-related Macular Degeneration Using Deep Learning

19 May, 2020 | 04:11h | UTC

Predicting conversion to wet age-related macular degeneration using deep learning – Nature Medicine (link to abstract – $ for full-text)

Commentary: Using AI to predict retinal disease progression – Deep Mind

 


Systematic Review: Treatment Regimens for Administration of Anti‐vascular Endothelial Growth Factor Agents for Neovascular Age‐related Macular Degeneration

15 May, 2020 | 03:18h | UTC

Treatment regimens for administration of anti‐vascular endothelial growth factor agents for neovascular age‐related macular degeneration – Cochrane Library

 


Characteristics of Ocular Findings of Patients With Coronavirus Disease

1 Apr, 2020 | 05:43h | UTC

Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China – JAMA Ophthalmology

Invited Commentary: Humans, Viruses, and the Eye—An Early Report From the COVID-19 Front Line – JAMA Ophthalmology

See also: Perspectives on Coronavirus Disease 2019 Control Measures for Ophthalmology Clinics Based on a Singapore Center Experience – JAMA Ophthalmology

 


Study: Low Risk of Coronavirus Spreading Through Tears

26 Mar, 2020 | 02:10h | UTC

Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients – Ophthalmology

Commentary: Low risk of coronavirus spreading through tears – American Academy of Ophthalmology

 


Review: Drugs for Some Common Eye Disorders

9 Feb, 2020 | 20:15h | UTC

Drugs for Some Common Eye Disorders – JAMA (free for a limited period)

If the link above does not work, try this one

 

Related Commentary on Twitter

 


Evaluation and Management of Sports-Related Eye Injuries

6 Feb, 2020 | 02:02h | UTC

Evaluation and Management of Sports-Related Eye Injuries – Current Sports Medicine Reports (free)

 


[Abstract Only] Randomized Trial: Eplerenone Not Beneficial for Chronic Central Serous Chorioretinopathy in Patients with Active, Previously Untreated Disease

26 Jan, 2020 | 22:27h | UTC

Eplerenone for chronic central serous chorioretinopathy in patients with active, previously untreated disease for more than 4 months (VICI): a randomised, double-blind, placebo-controlled trial – The Lancet (link to abstract – $ for full-text)

Commentary: Researchers find drug used widely to treat eye condition has ‘no benefit’ – University of Bristol (free)

 


[Abstract Only] Randomized Trial: Teprotumumab for the Treatment of Active Thyroid Eye Disease

24 Jan, 2020 | 08:07h | UTC

Teprotumumab for the Treatment of Active Thyroid Eye Disease – New England Journal of Medicine (link to abstract – $ for full-text)

Commentary: Teprotumumab bests placebo for active thyroid eye disease – MedicalXpress (free)

 


Stay Updated in Your Specialty

No spam, just news.